Most Popular
-
1
Yoon's approval rating plunges to all-time low
-
2
Climate impacts set to cut 2050 global GDP by nearly a fifth
-
3
S. Korea votes in favor of Palestinian bid for UN membership
-
4
Russia's denial of entry of S. Korean national unrelated to bilateral ties: Seoul official
-
5
Bae Doo-na shares portraying Korean identity in Hollywood's 'Rebel Moon'
-
6
[From the Scene] Monks, Buddhists hail return of remains of Buddhas
![[From the Scene] Monks, Buddhists hail return of remains of Buddhas](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/19/20240419050617_0.jpg&u=20240419175937)
-
7
Medical schools granted enrollment quota flexibility for next year
-
8
Korean art gets spotlight at Venice Biennale 2024
-
9
Police uncover illegal gambling website made by teens, for teens
-
10
Yoon's approval rating sinks to all-time low following election loss
![[From the Scene] Monks, Buddhists hail return of remains of Buddhas](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/19/20240419050617_0.jpg&u=20240419175937)
Green Cross Labcell files patents for anti-cancer cells
By Ahn Sung-miPublished : July 8, 2016 - 14:48
[THE INVESTOR] Korean pharma firm Green Cross Labcell has applied for international patent protection for its natural killer cells that treat cancer patients, the company said on July 8.
The Green Cross affiliate had extracted cord blood from healthy donors to generate natural killer cells, a type of white blood cells in the immune system that attacks infections and potentially cancer-causing cell.
The Green Cross affiliate had extracted cord blood from healthy donors to generate natural killer cells, a type of white blood cells in the immune system that attacks infections and potentially cancer-causing cell.
The cord blood-derived natural killer cells, when injected into a cancer-patient, will attack tumors, halt cancer cell growth and reduces the risk of recurrence, the c ompany said.
“Thanks to the international patent application, Green Cross Labcell’s cancer treatment has expanded the scope of practices abroad,” said Hwang Yu-kyeong, director of the Institute of Cell Therapy at the Green Cross Labcell. “We will accelerate our research to vitalize the cord blood industry and to commercialize natural killer cell-based treatment soon to alleviate the pain of cancer patients.”
By Ahn Sung-mi (sahn@heraldcorp.com)
![[From the Scene] Monks, Buddhists hail return of remains of Buddhas](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/04/19/20240419050617_0.jpg&u=20240419175937)
![[KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/04/18/20240418050645_0.jpg&u=20240419100350)
![[Today’s K-pop] Illit drops debut single remix](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/04/19/20240419050612_0.jpg&u=)